參考文獻(xiàn)/References:
[1] JONESR M,NEISH A S.Gut microbiota in intestinal and liver disease[J].Annu Rev Pathol,2021,16:251-275.
[2] DOIFODE T,GIRIDHARAN V V,GENEROSO J S,et al.The impact of the microbiota-gut-brain axis on Alzheimer's disease pathophysiology[J].Pharmacol Res,2021,164:105314.
[3] LORENZO J.From the gut to bone: connecting the gut microbiota with Th17 T lymphocytes and postmenopausal osteoporosis[J].J Clin Invest,2021,131(5):e146619.
[4] CHENG M,TAN B,WU X,et al.Gut microbiota is involved in alcohol-induced osteoporosis in young and old rats through immune regulation[J].Front Cell Infect Microbiol,2021,11:636231.
[5] MEI F,MENG K,GU Z,et al.Arecanut(Areca catechu L.)seed polyphenol-ameliorated osteoporosis by altering gut microbiome via LYZ and the immune system in estrogen-deficient rats[J].J Agric Food Chem,2021,69(1):246-258.
[6] KHAIRALLAH P,NICKOLAS T.Bone and mineral disease in kidney transplant recipients[J].Clin J Am Soc Nephrol,2022,17(1):121-130.
[7] HUANG J F,ZHENG X Q,SUN X L,et al.Association between bone mineral density and severity of chronic kidney disease[J/OL].Int J Endocrinol,2020[2022-02-01].https://pubmed.ncbi.nlm.nih.gov/33193760.
[8] 喬小萬(wàn),鄧強(qiáng),李中鋒,等.基于“腎虛髓枯”理論探討骨質(zhì)疏松癥的病機(jī)及中藥治療[J].中國(guó)骨質(zhì)疏松雜志,2022,28(5):760-765.
[9] 張博,李炎,黃樹(shù)明.“腎通于腦”理論的科學(xué)實(shí)質(zhì)探析[J].遼寧中醫(yī)雜志,2022,49(1):62-64.
[10] 李慧,何曉娟,賈良良,等.腎主骨生髓與膝骨關(guān)節(jié)炎筋骨失養(yǎng)的關(guān)系[J].風(fēng)濕病與關(guān)節(jié)炎,2019,8(2):48-51.
[11] 張騫予,楊鶇祥,樓家暉.補(bǔ)腎中藥誘導(dǎo)骨髓間充質(zhì)干細(xì)胞增殖分化防治骨質(zhì)疏松的研究進(jìn)展[J].中華中醫(yī)藥學(xué)刊,2020,38(3):193-195.
[12] WEI Q,WANG B,HU H,et al.Icaritin promotes the osteogenesis of bone marrow mesenchymal stem cells via the regulation of sclerostin expression[J].Int J Mol Med,2020,45(3):816-824.
[13] 郭瀾,李莉,葛繼榮.從外泌體探討“腎主骨生髓”理論與骨質(zhì)疏松癥的關(guān)系[J].中國(guó)骨質(zhì)疏松雜志,2020,26(12):1852-1856.
[14] 尚奇,任輝,沈耿楊,等.基于腎主骨生髓理論探討老年性骨質(zhì)疏松癥的中醫(yī)治療[J].中醫(yī)雜志,2017,58(16):1433-1435.
[15] TROMBETTI A,STOERMANN C,CHEVALLEY T,et al.Alterations of bone microstructure and strength in end-stage renal failure[J].Osteoporos Int,2013,24(5):1721-1732.
[16] NICKOLAS T L,STEIN E,COHEN A,et al.Bone mass and microarchitecture in CKD patients with fracture[J].J Am Soc Nephrol,2010,21(8):1371-1380.
[17] 張也,郭亞雄,羅世杰,等.基于中醫(yī)脾腎-腦相通理論淺談孤獨(dú)癥譜系障礙[J].河南中醫(yī),2021,41(1):20-23.
[18] 蔡光先,劉柏炎.從干細(xì)胞分化研究“腎通于腦”的策略[J].湖南中醫(yī)學(xué)院學(xué)報(bào),2004,24(1):30-31.
[19] 張景欣,王智,馬明.杜仲對(duì)骨髓間充質(zhì)干細(xì)胞增殖和向神經(jīng)元分化的影響[J].世界中西醫(yī)結(jié)合雜志,2016,11(7):945-948.
[20] 許云騰,李西海.從腎-腦-骨軸初探絕經(jīng)后骨質(zhì)疏松骨內(nèi)穩(wěn)態(tài)失衡的機(jī)制[J].中華中醫(yī)藥雜志,2020,35(10):4797-4800.
[21] KELLY R R,SIDLES S J,LARUE A C,et al.Effects of neurological disorders on bone health[J].Front Psycho,2020,11:612366.
[22] OTTO E,KNAPSTEIN P R,JAHN D,et al.Crosstalk of brain and bone-clinical observations and their molecular bases[J].Int J Mol Sci,2020,21(14):4946.
[23] 趙鑫,王珊珊,趙楠楠,等.補(bǔ)腎益髓湯聯(lián)合針刺對(duì)腦梗死后輕度認(rèn)知障礙認(rèn)知功能改善、腦血流動(dòng)力學(xué)及腦紅蛋白水平影響[J].遼寧中醫(yī)藥大學(xué)學(xué)報(bào),2022,24(2):140-144.
[24] 馬祥雪,王鳳云,符竣杰,等.基于腸道菌群的中醫(yī)健脾方劑作用機(jī)制的研究現(xiàn)狀與思考[J].中國(guó)實(shí)驗(yàn)方劑學(xué)雜志,2017,23(5):210-215.
[25] 朱文芳,孫克偉,陳斌,等.乙型肝炎相關(guān)性肝衰竭不同黃疸證的腸道菌群分析[J].湖南中醫(yī)藥大學(xué)學(xué)報(bào),2013,33(1):128-131.
[26] 于海洋,王志勇,汪海燕,等.基于“腸道微生態(tài)”談中醫(yī)學(xué)從“脾”論治骨質(zhì)疏松癥的科學(xué)內(nèi)涵[J].中國(guó)骨質(zhì)疏松雜志,2021,27(3):459-462.
[27] MEIJERS B K I,EVENEPOEL P.The gut-kidney axis:indoxyl sulfate,p-cresyl sulfate and CKD progression[J].Nephrol Dial Transplant,2011,26(3):759-761.
[28] RAMOS C I,ARMANI R G,CANZIANI M E F,et al.Effect of prebiotic(fructooligosaccharide)on uremic toxins of chronic kidney disease patients:a randomized controlled trial[J].Nephrol Dial Transplant,2019,34(11):1876-1884.
[29] ZHANG W,MIIKEDA A,ZUCKERMAN J,et al.Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice[J].Sci Rep,2021,11(1):518.
[30] 鄒川,吳禹池,楊麗虹,等.結(jié)合腸腎軸理論探討中醫(yī)藥從結(jié)腸治療慢性腎臟病的研究思路[J].世界科學(xué)技術(shù)-中醫(yī)藥現(xiàn)代化,2013,15(5):947-951.
[31] 李雅方,梁瑞瓊,邱鴻鐘.中西醫(yī)關(guān)于菌-腸-腦軸與失眠關(guān)聯(lián)機(jī)制的探討[J].世界科學(xué)技術(shù)-中醫(yī)藥現(xiàn)代化,2020,22(7):2494-2498.
[32] MORAIS L H,SCHREIBER H L 4th.The gut microbiota-brain axis in behaviour and brain disorders[J].Nat Rev Microbiol,2021,19(4):241-255.
[33] CRYAN J F,O'RIORDAN K J,COWAN C S M,et al.The Microbiota-Gut-Brain Axis[J].Physiol Rev,2019,99(4):1877-2013.
[34] WALLIMANN A,MAGRATH W,THOMPSON K,et al.Gut microbial-derived short-chain fatty acids and bone:a potential role in fracture healing[J].Eur Cell Mater,2021,41:454-470.
[35] 張倩璐,江婷,趙國(guó)軍.脂多糖抑制成骨細(xì)胞分化作用研究[J].中國(guó)臨床藥理學(xué)雜志,2019,35(21):2743-2746.
[36] WANG Z,YU Y,LIAO J,et al.S-Propargyl-Cysteine remodels the gut microbiota to alleviate rheumatoid arthritis by regulating bile acid metabolism[J].Front Cell Infect Microbiol,2021,11:670593.
[37] WHISNER C M,MARTIN B R,NAKATSU C H,et al.Soluble maize fibre affects short-term calcium absorption in adolescent boys and girls:a randomised controlled trial using dual stable isotopic tracers[J].Br J Nutr,2014,112(3):446-456.
[38] ROSHCHINA V V.New trends and perspectives in the evolution of neurotransmitters in microbial, plant, and animal cells[J].Adv Exp Med Biol,2016,874:25-77.
[39] YUAN S,SHEN J.Bacteroides vulgatus diminishes colonic microbiota dysbiosis ameliorating lumbar bone loss in ovariectomized mice[J].Bone,2021,142:115710.
[40] YANO J M,YU K,DONALDSON G P,et al.Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis[J].Cell,2015,161(2):264-276.
[41] 江孝龍,蔣國(guó)華.老年骨質(zhì)疏松患者血清瘦素、胰島素樣生長(zhǎng)因子-Ⅰ、組織蛋白酶K和氧化應(yīng)激指標(biāo)的水平及意義[J].中國(guó)老年學(xué)雜志,2018,38(12):2954-2956.
[42] ZHANGB,YANG L,ZENG Z,et al.Leptin potentiates bmp9-induced osteogenic differentiation of mesenchymal stem cells through the activation of jak/stat signaling[J].Stem Cells Dev,2020,29(8):498-510.
[43] 黃宏興,吳青,李躍華,等.肌肉、骨骼與骨質(zhì)疏松專家共識(shí)[J].中國(guó)骨質(zhì)疏松雜志,2016,22(10):1221-1229.
[44] 張文達(dá),胡美思,任艷玲.基于AMPK/mTOR信號(hào)通路探討左、右歸丸對(duì)絕經(jīng)后骨質(zhì)疏松癥大鼠骨吸收的影響[J].中華中醫(yī)藥雜志,2021,36(3):1379-1383.
[45] 周強(qiáng).左歸丸對(duì)骨質(zhì)疏松癥大鼠骨、腎、下丘腦GPR48、CREB、BMP9影響的實(shí)驗(yàn)研究[D].沈陽(yáng):遼寧中醫(yī)藥大學(xué),2016.
[46] 姜坤.右歸丸對(duì)骨質(zhì)疏松癥大鼠骨、腎、下丘腦PKA、CREB及ATF4蛋白表達(dá)的影響[D].沈陽(yáng):遼寧中醫(yī)藥大學(xué),2016.
[47] 肖麗,龍抗勝,薛智慧,等.電針對(duì)去勢(shì)大鼠骨密度及下丘腦中瘦素與瘦素受體的影響[J].時(shí)珍國(guó)醫(yī)國(guó)藥,2016,27(8):2031-2033.
[48] 胡栢均,吳宇峰.伍中慶教授歸脾湯治療骨質(zhì)疏松癥的經(jīng)驗(yàn)[J].光明中醫(yī),2011,26(6):1102-1104.
[49] 王翔,趙詠芳,石印玉,等.健脾方對(duì)去勢(shì)大鼠維生素D代謝的影響[J].中國(guó)骨質(zhì)疏松雜志,2007,13(6):429-432.
[50] 孔源,宮云昭,王瑩,等.補(bǔ)腎健脾方對(duì)去卵巢誘導(dǎo)大鼠骨質(zhì)疏松的作用及其機(jī)制研究[J].中華中醫(yī)藥學(xué)刊,2021,39(8):175-179.
[51] SCHEPPER J D,COLLINS F,RIOS-ARCE N D,et al.Involvement of the gut microbiota and barrier function in glucocorticoid-induced osteoporosis[J].J Bone Miner Res,2020,35(4):801-820.
[52] LIU H,GU R,LI W,et al.Lactobacillus rhamnosus GG attenuates tenofovir disoproxil fumarate-induced bone loss in male mice via gut-microbiota-dependent anti-inflammation[J].Ther Adv Chronic Dis,2019,10:2040.
[53] 王聰聰,龔敏,王立紅,等.補(bǔ)腎健脾活血湯聯(lián)合西醫(yī)常規(guī)療法治療糖尿病骨質(zhì)疏松癥臨床研究[J].國(guó)際中醫(yī)中藥雜志,2020,42(10):955-959.
[54] 顏春魯,安方玉,汪永鋒,等.右歸丸對(duì)大鼠膝骨關(guān)節(jié)炎的干預(yù)作用及其機(jī)制[J].中國(guó)應(yīng)用生理學(xué)雜志,2020,36(5):511-516.
[55] 馬成.六味地黃湯加味治療老年膝骨關(guān)節(jié)炎(肝腎陰虛證)的臨床觀察[D].長(zhǎng)沙:湖南中醫(yī)藥大學(xué),2020.
[56] 蔡玉梅,黃文燕,鄭繼范,等.從脾胃論治膝骨關(guān)節(jié)炎的臨床研究[J].針灸臨床雜志,2011,27(3):28-29.
[57] HUANG Z Y,CHEN J,LI B L,et al.Faecal microbiota transplantation from metabolically compromised human donors accelerates osteoarthritis in mice[J].Annals of the rheumatic diseases,2020,79(5):646-656.
[58] 盧耀鳴,郭達(dá),盧曉敏,等.中國(guó)廣東地區(qū)膝骨關(guān)節(jié)炎患者與健康人群腸道菌群差異性分析[J].中國(guó)骨質(zhì)疏松雜志,2020,26(11):1679-1684.
[59] 馬秉楠,關(guān)玉波,陳長(zhǎng)鋒,等.補(bǔ)腎生髓強(qiáng)骨方對(duì)酒精性股骨頭壞死模型大鼠炎癥因子、氧化應(yīng)激及TLR4、NF-κB和VEGF蛋白表達(dá)的影響[J].中國(guó)中醫(yī)急癥,2020,29(12):2125-2128.
[60] 李中峰,陳明海,凡一諾,等.右歸飲治療激素性股骨頭壞死作用機(jī)制的網(wǎng)絡(luò)藥理學(xué)分析[J].中國(guó)組織工程研究,2021,25(8):1256-1263.
[61] 劉鋅,杜斌,高麗麗,等.右歸飲干預(yù)激素性股骨頭壞死大鼠骨髓間充質(zhì)干細(xì)胞的自噬及命運(yùn)[J].中國(guó)組織工程研究,2021,25(1):20-25.
[62] 劉鋅,金翔,杜斌,等.右歸飲加減方對(duì)兔激素性股骨頭壞死的干預(yù)作用及其機(jī)制研究[J].江蘇中醫(yī)藥,2019,51(9):81-85.
[63] 張申堯.補(bǔ)腎健脾通絡(luò)方輔治激素性股骨頭壞死臨床觀察[J].實(shí)用中醫(yī)藥雜志,2019,35(7):841-842.
[64] 李濤,李秋梅,董玉娟.健脾補(bǔ)腎通絡(luò)方結(jié)合銀質(zhì)針治療股骨頭缺血性壞死的臨床觀察[J].寧夏醫(yī)學(xué)雜志,2020,42(6):560-562.
[65] GURWARA S,DAI A,AJAMI N J,et al.Alcohol use alters the colonic mucosa-associated gut microbiota in humans[J].Nutr Res,2020,83:119-128.
[66] BLUEMEL S,WANG L,KUELBS C,et al.Intestinal and hepatic microbiota changes associated with chronic ethanol administration in mice[J].Gut Microbes,2020,11(3):265-275.
[67] 陸萬(wàn)里,李同林,卞恒杰,等.血清瘦素、骨保護(hù)素與特發(fā)性股骨頭壞死相關(guān)性研究[J].中國(guó)醫(yī)藥科學(xué),2020,10(21):18-22.
[68] QUEIPO-ORTUÑO M I,SEOANE L M,MURRI M,et al.Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels[J].PLoS One,2013,8(5):e65465.
[69] 周麗華.穴位按摩聯(lián)合音樂(lè)療法對(duì)股骨頭壞死患者心理狀態(tài)及生活質(zhì)量的影響[J].中外醫(yī)學(xué)研究,2019,17(28):175-177.